depression and semaglutide GLP-1s linked to lower rates of anxiety than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement #Naltrexone Obesity drugs like Wegovy may

Thirty-day oral gavage exposure to PET NPs (mean diameter 62 nm

A comparison showed that the treatment with NP4 resulted in the highest amount of lipid peroxides (Supplementary Fig

Improved hydration and skin barrier support: Maintaining a healthy skin barrier is essential for hydration, resilience and protection from irritation

Additionally, on April 30, 2026, one of Novo Nordisks competitors completed phase three of a clinical trial of a drug that they hope will help people lose weight and reduce liver fat. The clinical trial involved people who have obesity or are overweight and have also been diagnosed with a specific type of liver disease

For glaucoma and eye problems: BPC-157 has shown efficacy in many animal studies and a couple of preclinical trials for eye problems